Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tracking Federal Agencies’ Enforcement In Supplement Space

This article was originally published in The Tan Sheet

Executive Summary

““The Tan Sheet” provides links to previous articles on many of the enforcements DoJ announced from its year-long sweep.


Related Content

Enforcement Roundup: Daniel Chapter One, Peanut Corp. Of America
Industry Roundup: SEC Fines MJN, Criminal Charge For Herbals Seller, Decree Closes Aspen Supplement Marketer
Missing CAPA Costs J&J $25 Million In Investigation Sparked By OTC Recalls
Homeopathic Claims Have FTC Searching For Remedy To Regulatory Conflict With FDA
Industry News Roundup
Weight Loss Claims Land Firms On FTC Radar In First ‘Negative Option’ Case
Consent Decrees Are Last “Dance” For Supplement GMP Violators
Regulatory News In Brief
Venus Consent Decree Shows Cost Of Flouting GMP Warning
FDA Expects STD Claims Enforcement To Deter Future Violations


Related Companies

Related Deals

What to read next




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts